Precision Biosciences (DTIL) Change in Cash (2018 - 2026)

Precision Biosciences (DTIL) has reported Change in Cash for 9 consecutive years, with -$11.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash fell 30.27% year-over-year to -$11.3 million; the TTM figure through Mar 2026 stood at $26.1 million (up 168.62% YoY), while the FY2025 annual figure was $28.7 million, up 449.39% from the prior year.
• Change in Cash declined to -$11.3 million in Q1 2026 per DTIL's latest filing, from $65.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $67.9 million in Q2 2022 and bottomed at -$31.4 million in Q1 2023.
• Historically, Change in Cash has averaged -$1.0 million across 5 years, with a median of -$12.9 million in 2024.
• On a YoY basis, Change in Cash climbed as much as 612.76% in 2025 and fell as far as 506.06% in 2025.
• Precision Biosciences' Change in Cash stood at -$22.5 million in 2022, then surged by 75.29% to -$5.6 million in 2023, then tumbled by 131.59% to -$12.9 million in 2024, then soared by 612.76% to $65.9 million in 2025, then tumbled by 117.15% to -$11.3 million in 2026.
• Business Quant data shows DTIL's Change in Cash at -$11.3 million in Q1 2026, $65.9 million in Q4 2025, and -$13.6 million in Q3 2025.